Department of Economics and Business Economics

Competitive tenders on analogue hospital pharmaceuticals in Denmark 2017–2020

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Lars Holger Ehlers, Nordic Institute of Health Economics, Aalborg University
  • ,
  • Morten B. Jensen
  • Henrik Schack, Aalborg University

Background: Competitive tenders on pharmaceuticals are one of the most effective cost-containment instruments in healthcare systems. Its effectiveness has been demonstrated, among other things, in markets for generic medicine and biosimilars. In Denmark, an internationally unique model for competitive tenders on analogue substitutable pharmaceuticals has been developed and implemented for all public hospitals. Methods: We obtained data on all analogue competitive tenders carried out by the Danish Medicines Council from its foundation on January 1, 2017, to October 9, 2020. We calculated univariate descriptive statistics, pairwise correlations and made a multiple regression analysis on tender savings. Results: Average annual saving on hospital pharmaceutical purchase prices was 44.1% ranging from 0.4% to 92.8% between therapeutic areas and areas of indication. There was a significant positive correlation between tender savings and the number of competitors participating in the tender, and a significant negative correlation between tender savings and the number of days since market authorization. Conclusions: This study finds analogue tenders to be similar in effect and mechanism to competitive tenders in markets for generic medicine and biosimilars. It supports the increasing number of empirical findings that competitive tendering has a high potential to generate substantial savings on healthcare budgets.

Original languageEnglish
Article number69
JournalJournal of Pharmaceutical Policy and Practice
Volume15
ISSN2052-3211
DOIs
Publication statusPublished - Oct 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

    Research areas

  • Analogue competition healthcare cost, Competitive tenders on pharmaceuticals, Cost-containment, Managing access to medicine, Public procurement, Tender system

See relations at Aarhus University Citationformats

ID: 286824319